(55 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
{{NTHU_Formosa}} {{NTHU_Formosa/NavBar}} | {{NTHU_Formosa}} {{NTHU_Formosa/NavBar}} | ||
<html> | <html> | ||
+ | |||
<head> | <head> | ||
− | <link rel="stylesheet" | + | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/Lato&action=raw&ctype=text/css" /> |
− | + | ||
− | + | ||
<link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/CSS&action=raw&ctype=text/css"> | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/CSS&action=raw&ctype=text/css"> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/CSS2&action=raw&ctype=text/css"> | ||
<link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/initial&action=raw&ctype=text/css"> | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/initial&action=raw&ctype=text/css"> | ||
− | <link rel="stylesheet" type="text/css" href="// | + | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/wordcss0&action=raw&ctype=text/css"> |
+ | <link rel="stylesheet" type="text/css" href="https://2018.igem.org/wiki/index.php?title=Template:NTHU_Formosa/wordcss&action=raw&ctype=text/css"> | ||
<style> | <style> | ||
Line 34: | Line 35: | ||
color: blue; | color: blue; | ||
} | } | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</style> | </style> | ||
</head> | </head> | ||
− | |||
− | |||
− | |||
<div class="w3-container w3-padding-64 w3-center"> | <div class="w3-container w3-padding-64 w3-center"> | ||
<div class="w3-content" style="font-family: " Microsoft YaHei ",Helvetica,sans-serif;"> | <div class="w3-content" style="font-family: " Microsoft YaHei ",Helvetica,sans-serif;"> | ||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
+ | <h2 class="w3-wide" style="font-size:60px;font-family:Quicksand;">Composite Part</h2> | ||
+ | <br> | ||
+ | <br> | ||
− | <p class="w3-center" style="font-size: | + | <p class="w3-center" style="font-size:30px;font-family:Quicksand;"><a href="http://parts.igem.org/Part:BBa_K2635000">Part: BBa_K2635000</a></p> |
− | + | <br> | |
− | + | <br> | |
− | + | <img class="w3-round-large" src="https://static.igem.org/mediawiki/2018/2/2c/T--NTHU_Formosa--BIOBRICK_03_03.png" style="margin-left:auto;margin-right:auto;width:13%;" ;> | |
− | + | <br> | |
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
+ | <p class="w3-justify" style="font-size:25px;"><b>pTRE3G-mCherry</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;"> | ||
+ | This is one of the output signals in our reporter cell during experiments. As the transcription factor, tTA, binds to TRE3G promoter regulating the downstream gene, mCherry is expressed. In our design, a series of reaction followed by the presence of | ||
+ | GFP will release tTA, which will be translocated into the nucleus</p> | ||
+ | <br> | ||
+ | <br> | ||
− | |||
− | |||
− | |||
+ | <p class="w3-center" style="font-size:30px;font-family:Quicksand;"><a href="http://parts.igem.org/Part:BBa_K2635001">Part: BBa_K2635001</a></p> | ||
+ | <br> | ||
+ | <br> | ||
+ | <img class="w3-round-large" src="https://static.igem.org/mediawiki/2018/9/94/T--NTHU_Formosa--GBPpart.png" style="margin-left:auto;margin-right:auto;width:60%;" ;> | ||
+ | <br> | ||
+ | <p class="w3-justify" style="font-size:25px;"><b>pCAG-GBP</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">This is a full composite part, split-GBP-tTA, of our detecting system in the reporter cells. As the split nanobodies segments being brought together by ligands, the split TEV protease segments conjugated to split-GBP are brought together and become | ||
+ | functional. The functional TEV protease recognize and cleave at the TEV cutting site, followed by the translocation of tTA transcription factor into the nucleus, where tTA triggers the emission of output signal. To be certain that the release of | ||
+ | tTA is only by TEV cutting, we add NES sequence in this detecting system.</p> | ||
+ | <br> | ||
− | |||
− | |||
+ | <p class="w3-justify" style="font-size:25px;"><b>Igk-chain leader sequence</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">A short peptide presented at the N-terminus of newly synthesized proteins that helps target to the secretory pathway.</p> | ||
+ | <br> | ||
− | |||
− | |||
− | <p class="w3-justify" style="font-size:25px;"> | + | <p class="w3-justify" style="font-size:25px;"><b>PDGFR TM domain</b></p> |
− | <p class="w3-justify" style="font-size:20px;"> | + | <p class="w3-justify" style="font-size:20px;">This is a transmembrane fusion protein that anchors split-GBP-tTA on plasma membrane. It is commonly used in mammalian cells for expression of protein on surface.</p> |
+ | <br> | ||
− | |||
− | |||
− | <p class="w3-justify" style="font-size:25px;"> | + | <p class="w3-justify" style="font-size:25px;"><b>GBP N-terminal/ C-terminal</b></p> |
− | <p class="w3-justify" style="font-size:20px;"> | + | <p class="w3-justify" style="font-size:20px;">Green fluorescent protein (GFP) and GFP-binding protein (GBP) system is a very common tool in synthetic biology. We use GFP-nanobody(GBP), a single-chain VHH antibody domain developed with specific binding activity against GFP, because it is the most |
+ | well-studied nanobody. In our design, we segregate GFP-nanobody into two fragments, C-terminal and N-terminal outside the membrane. Both fragment have it own C-terminal or N-terminal TEV protease fragment linked by TM domain. When GFP appears, both | ||
+ | of the C-terminal and N-terminal of GBP bind to it. This movement facilitates the combination of C-terminal and N-terminal TEV protease in the cytosol, and then the intact TEV protease starts to cut at TEV cleavage site. <sup>[1][2]</sup></p> | ||
+ | <br> | ||
+ | <p class="w3-justify" style="font-size:25px;"><b>NES sequence</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">The protein targeted by nuclear export signal (NES) will be exported from the cell nucleus to the cytosol. We use this characteristic to avoid the whole designed proteins going into the nucleus and cause the output signal emission with the uncleaved | ||
+ | tTA. The position of NES sequence is designed to locate between TEV fragments and TEV cleavage site.</p> | ||
+ | <br> | ||
+ | <p class="w3-justify" style="font-size:25px;"><b>TEV protease N-terminal/ C-terminal</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">TEV proteases are the 27 kDa catalytic domains of the NIa (Nuclear Inclusion a) protein encoded by Tobacco Etch Virus (TEV), where TEV proteases cut polyproteins into single proteins during biogenesis. In our design, TEV protease is split into N-terminal | ||
+ | and C-terminal fragments. When split GBP is brought together by the presence of GFP, the two TEV protease fragments will combine and cleave TEV cutting sites. After the cleavage, tTA is freed and translocated in to the nucleus and bind to TRE3G, | ||
+ | the promoter driving output emission signal.<sup>[3]</sup></p> | ||
+ | <br> | ||
− | |||
− | |||
+ | <p class="w3-justify" style="font-size:25px;"><b>TEV cleavage site ENLYFQL/ ENLYFQG</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">TEV proteases recognize a linear epitope composed of 7 amino acids and cut the linkage between the last and the second-last amino acid. The high specificity of cutting amino acid linkages makes it a popular tool for direct expression in living cells | ||
+ | and protein purification. In our design, we use ENLYFQL at TEV N-terminal and ENLYFQG at TEV C-terminal as cutting site according to Baeumler’s paper in 2017.<sup>[4]</sup></p> | ||
+ | <br> | ||
− | |||
− | |||
− | |||
+ | <p class="w3-justify" style="font-size:25px;"><b>tTA</b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;">The tetracycline transactivator (tTA) is the main character in Tetracycline-controlled gene expression. tTA binds to TetO operator, which regulates the expression of a transgene. We use this system to regulate the transgene of our proteins, which | ||
+ | emit signal as output.In our design, tTA is a combination of tTa binding site and VP16, a transcription activator which triggers conformational change upon binding to the promoter. When tTA is released, it binds to TRE3G, containing several TetO | ||
+ | sequence and a minimal promoter, tetracycline response element TRE. The binding of tTA and TRE3G will trigger the expression of downstream gene.<sup>[5]</sup></p> | ||
+ | <br> | ||
− | |||
− | |||
− | In our design, we have tTA sequence located between two NLS sequences, which help import our tTA into the nucleus after the TEV cleavage site being cut by the TEV protease.</p><br><br> | + | <p class="w3-justify" style="font-size:25px;"><b>NLS</b></p> |
+ | <p class="w3-justify" style="font-size:20px;">A NLS (Nuclear Localization sequence) is an amino acid sequence that 'tags' a protein, which will consequently be imported into the cell nucleus by nuclear transport. It’s function is opposite to NES sequence.In our design, we have tTA sequence located | ||
+ | between two NLS sequences, which help import our tTA into the nucleus after the TEV cleavage site being cut by the TEV protease.</p> | ||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
− | |||
− | |||
− | |||
− | |||
+ | <p class="w3-justify" style="font-size:25px;"><b>Reference: </b></p> | ||
+ | <p class="w3-justify" style="font-size:20px;"> | ||
+ | 1. Kubala, M. H., Kovtun, O., Alexandrov, K., &Collins, B. M. (2010). Structural and thermodynamic analysis of the GFP : GFP-nanobody complex.Protein Sci. 2010 Dec;19(12):2389-401. doi: 10.1002/pro.519. | ||
+ | <br> 2. Tang, J. C. Y., Rudolph, S., Dhande, O. S., Abraira, V. E., Choi, S., Lapan, S. W., …Cepko, C. L. (2015). Cell type-specific manipulation with GFP-dependent Cre recombinase. Nature Neuroscience, 18(9), 1334–1341. | ||
+ | <br> 3. Baeumler, T. A., Ahmed, A. A., &Fulga, T. A. (2017). Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors. Cell Reports, 20(11), 2639-2653. | ||
+ | <br> | ||
+ | </p> | ||
+ | <p class="w3-justify" style="font-size:20px;"></p> | ||
− | </div> | + | </div> |
</div> | </div> | ||
Latest revision as of 00:54, 18 October 2018
Composite Part
pTRE3G-mCherry
This is one of the output signals in our reporter cell during experiments. As the transcription factor, tTA, binds to TRE3G promoter regulating the downstream gene, mCherry is expressed. In our design, a series of reaction followed by the presence of GFP will release tTA, which will be translocated into the nucleus
pCAG-GBP
This is a full composite part, split-GBP-tTA, of our detecting system in the reporter cells. As the split nanobodies segments being brought together by ligands, the split TEV protease segments conjugated to split-GBP are brought together and become functional. The functional TEV protease recognize and cleave at the TEV cutting site, followed by the translocation of tTA transcription factor into the nucleus, where tTA triggers the emission of output signal. To be certain that the release of tTA is only by TEV cutting, we add NES sequence in this detecting system.
Igk-chain leader sequence
A short peptide presented at the N-terminus of newly synthesized proteins that helps target to the secretory pathway.
PDGFR TM domain
This is a transmembrane fusion protein that anchors split-GBP-tTA on plasma membrane. It is commonly used in mammalian cells for expression of protein on surface.
GBP N-terminal/ C-terminal
Green fluorescent protein (GFP) and GFP-binding protein (GBP) system is a very common tool in synthetic biology. We use GFP-nanobody(GBP), a single-chain VHH antibody domain developed with specific binding activity against GFP, because it is the most well-studied nanobody. In our design, we segregate GFP-nanobody into two fragments, C-terminal and N-terminal outside the membrane. Both fragment have it own C-terminal or N-terminal TEV protease fragment linked by TM domain. When GFP appears, both of the C-terminal and N-terminal of GBP bind to it. This movement facilitates the combination of C-terminal and N-terminal TEV protease in the cytosol, and then the intact TEV protease starts to cut at TEV cleavage site. [1][2]
NES sequence
The protein targeted by nuclear export signal (NES) will be exported from the cell nucleus to the cytosol. We use this characteristic to avoid the whole designed proteins going into the nucleus and cause the output signal emission with the uncleaved tTA. The position of NES sequence is designed to locate between TEV fragments and TEV cleavage site.
TEV protease N-terminal/ C-terminal
TEV proteases are the 27 kDa catalytic domains of the NIa (Nuclear Inclusion a) protein encoded by Tobacco Etch Virus (TEV), where TEV proteases cut polyproteins into single proteins during biogenesis. In our design, TEV protease is split into N-terminal and C-terminal fragments. When split GBP is brought together by the presence of GFP, the two TEV protease fragments will combine and cleave TEV cutting sites. After the cleavage, tTA is freed and translocated in to the nucleus and bind to TRE3G, the promoter driving output emission signal.[3]
TEV cleavage site ENLYFQL/ ENLYFQG
TEV proteases recognize a linear epitope composed of 7 amino acids and cut the linkage between the last and the second-last amino acid. The high specificity of cutting amino acid linkages makes it a popular tool for direct expression in living cells and protein purification. In our design, we use ENLYFQL at TEV N-terminal and ENLYFQG at TEV C-terminal as cutting site according to Baeumler’s paper in 2017.[4]
tTA
The tetracycline transactivator (tTA) is the main character in Tetracycline-controlled gene expression. tTA binds to TetO operator, which regulates the expression of a transgene. We use this system to regulate the transgene of our proteins, which emit signal as output.In our design, tTA is a combination of tTa binding site and VP16, a transcription activator which triggers conformational change upon binding to the promoter. When tTA is released, it binds to TRE3G, containing several TetO sequence and a minimal promoter, tetracycline response element TRE. The binding of tTA and TRE3G will trigger the expression of downstream gene.[5]
NLS
A NLS (Nuclear Localization sequence) is an amino acid sequence that 'tags' a protein, which will consequently be imported into the cell nucleus by nuclear transport. It’s function is opposite to NES sequence.In our design, we have tTA sequence located between two NLS sequences, which help import our tTA into the nucleus after the TEV cleavage site being cut by the TEV protease.
Reference:
1. Kubala, M. H., Kovtun, O., Alexandrov, K., &Collins, B. M. (2010). Structural and thermodynamic analysis of the GFP : GFP-nanobody complex.Protein Sci. 2010 Dec;19(12):2389-401. doi: 10.1002/pro.519.
2. Tang, J. C. Y., Rudolph, S., Dhande, O. S., Abraira, V. E., Choi, S., Lapan, S. W., …Cepko, C. L. (2015). Cell type-specific manipulation with GFP-dependent Cre recombinase. Nature Neuroscience, 18(9), 1334–1341.
3. Baeumler, T. A., Ahmed, A. A., &Fulga, T. A. (2017). Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors. Cell Reports, 20(11), 2639-2653.